Armata Pharmaceuticals Inc (ARMP)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Brian C. Varnum
Employees:
70
4503 GLENCOE AVENUE MARINA DEL REY CA 90292
310-665-2928

Armata Pharmaceuticals, Inc. focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PS03 for pneumonia.

Data derived from most recent annual or quarterly report
Market Cap 152.393 Million Shares Outstanding36.112 Million Avg 30-day Volume 5.535 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue26.1315 Debt to Equity0.0 EBITDA-29.174 Million
Price to Book Value2.6278 Operating Margin-563.2767 Enterprise Value103.061 Million
Current Ratio5.595 EPS Growth0 Quick Ratio5.009
1 Yr BETA 0.4338 52-week High/Low 6.49 / 2.82 Profit Margin-549.6361
Operating Cash Flow Growth-24.9072 Altman Z-Score-1.8302 Free Cash Flow to Firm -26.36 Million
View SEC Filings from ARMP instead.

View recent insider trading info

Funds Holding ARMP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARMP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-09-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-31:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2021-05-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PATTI JOSEPH M

    • Director
    33,000 2022-04-13 1

    HAIMOVITZ JULES

    • Director
    33,000 2022-04-13 1

    ODYSSEAS KOSTAS D

    • Director
    33,000 2022-04-13 1

    SCHLESINGER SARAH J.

    • Director
    33,000 2022-04-13 1

    KRAMER ROBIN

    • Director
    33,000 2022-04-13 1

    PATRICK TODD

    • Director
    33,000 2022-04-13 1

    MORRIS DUANE ALFRED VP OF OPERATIONS

    • Officer
    41,000 2022-04-13 1

    VARNUM BRIAN PRESIDENT AND CEO

    • Officer
    240,000 2022-04-13 1

    PETERSON TODD C.

    • Director
    33,000 2022-04-13 1

    INNOVIVA, INC.

    INNOVIVA STRATEGIC OPPORTUNITIES LLC

    • Director
    • 10% Owner
    44,441,416 2022-03-31 3

    MARTIN STEVEN ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    56,000 2021-03-25 0

    BASTIANI RICHARD

    • Director
    0 2020-12-08 0

    INNOVIVA, INC.

    • 10% Owner
    17,421,600 2020-03-27 3

    COOK JEREMY CURNOCK

    • Director
    0 2019-12-31 0

    PERRY MICHAEL S

    • Director
    No longer subject to file 2019-12-31 0

    PARKER H STEWART

    • Director
    0 2019-05-22 0

    BEAR RICHARD

    • Director
    0 2019-05-22 0

    DELTA DENTAL PLAN OF MICHIGAN, INC.

    RENAISSANCE HOLDING CO

    • 10% Owner
    1,265,802 2019-05-09 0

    DELTA DENTAL OF WISCONSIN, INC.

    • 10% Owner
    2,107,675 2019-05-09 0

    GRINT PAUL C CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    599 2017-12-08 0

    SAMANT VIJAY B

    • Director
    0 2017-09-07 0

    DRAPEAU LOUIS

    • Director
    0 2017-09-07 0

    JOHNSON WENDY S.

    • Director
    0 2017-09-07 0

    BILINSKY IGOR CHIEF OPERATING OFFICER

    • Officer
    0 2017-05-30 0

    SALKA MICHAEL SCOTT CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2017-04-01 0

    KIRK RANDAL J

    INTREXON CORP

    • 10% Owner
    No longer subject to file 2016-12-27 0

    KIRK JULIAN P.

    • Director
    0 2015-09-21 0

    WILLIAMS GWYNN

    • 10% Owner
    0 2014-02-18 0

    YOUNG PHILIP J PRESIDENT AND CEO

    • Officer
    • Director
    0 2014-02-18 0

    WENDT KELLEY A CHIEF FINANCIAL OFFICER

    • Officer
    0 2014-02-18 0

    POSTON DAVID J VICE PRESIDENT AND CFO

    • Officer
    220,576 2010-04-16 0

    ROBINSON BG SUSAN PRESIDENT AND CEO

    • Officer
    • Director
    310,814 2010-04-16 0

    MARXE AUSTIN W & GREENHOUSE DAVID M

    • 10% Owner
    0 2009-10-09 0

    DAVIE JOSEPH MD PHD

    • Director
    0 2009-05-29 0

    LEVY NELSON L

    • Director
    0 2009-05-29 0

    HAWLEY ROGER

    • Director
    0 2009-05-29 0

    CARTER BARRIE J PHD EXECUTIVE VICE PRESIDENT

    • Officer
    83,766 2008-05-15 0

    BOWMAN JACK L

    • Director
    10,500 2007-05-17 0

    BIOGEN IDEC INC

    BIOGEN IDEC MA INC

    • 10% Owner
    2,170,410 2006-11-07 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 22:15:04 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 21:45:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 21:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 20:45:04 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 20:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 19:45:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 19:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 18:45:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 18:15:04 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 17:45:04 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 17:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 16:45:04 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 16:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 15:45:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 15:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 14:45:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 14:15:03 UTC -25.2765 28.3465 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 13:45:03 UTC -25.2889 28.3589 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 13:15:03 UTC -25.2889 28.3589 20000
    ARMATA PHARMACEUTICALS INC ARMP 2022-09-30 12:45:03 UTC -25.2889 28.3589 20000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments